Section Review: Recent developments in the use of hyaluronan in wound healing:Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis

References

• MEYER K, PALMER JW: The polysaccharide of the vitre-ous humour. J. Biol. Chem. (1934) 107:629.
   Google Scholar
• LAURENT UBG, TENGBLAD A: Determination of hyaluronate in biological samples by a specific radio-assay technique. Anal. Biochem. (1980) 109:386–394.
   PubMed Web of Science ®Google Scholar
• DELPECH B, BERTRAND P, MAINGONNAT C: Immunoen-zymeassay of the hyaluronic add-hyaluronectin inter-action: application to the detection of hyaluronic acid In serum of normal subjects and cancer patients. Anal. Biochem. (1985) 149:555–565.
   PubMed Web of Science ®Google Scholar
• LAURENT TC, FRASER jRE: The properties and turnover of hyaluronan. In: Functions of the proteoglycans. Ciba Foundation Symposium 124. Wiley, Chichester (1986):9–29.
   Google Scholar
• LAURENT TC: Biochemistry of hyaluronan. Ada Oto-laryngol. (1987) 442:7–24.
   PubMed Web of Science ®Google Scholar
• GOA la, BENFIELD P: Hyaluronic add: a review of its pharmacology and use as a surgical aid in ophthalmol-ogy, and its therapeutic potential in joint disease and wound healing. Drugs (1994) 47:536–566.
   PubMed Web of Science ®Google Scholar
• This review shows the clinical use of hyaluronan in ophthalmology, joint disease and wound healing.
   Google Scholar
• POLACK FM: Healon (Na hyaluronate). Cornea (1986) 5:81–93.
   Google Scholar
• BALAZS EA, DENLINGER JL: Clinical uses of hyaluronan.In: The Biology of Hyaluronan. Ciba Foundation Symposium 143. Wiley, Chichester (1989):265–280.
   Google Scholar
• LAURENT TC, FRASER .JRE: Hyaluronan. FASEB J. (1992) 6:2397–2404.
   PubMed Web of Science ®Google Scholar
• Hyaluronan is recognised as a potential therapeutic agent and a distinctive indicator of disease processes.
   Google Scholar
• Scarr.JE: Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues.EASES J. (1992) 6:2639–2645.
   Google Scholar
• This review shows the evidence for glycosaminoglycan secondary and tertiary structures in solution.
   Google Scholar
• TOOLE BP: Glycosaminoglycans in morphogenesis. In:Cell biology of extracellular matrix. Hay ED (Ed.). Plenum Press, New York (1981):259–294.
   Google Scholar
• TOOLE BP, MUNAIM SI, WELLES S, KNUDSON CB: Hyaluronate-cell interactions and growth factor regu-lation of hyaluronate synthesis during limb develop-ment. In: The Biology of Hyaluronan. Ciba Foundation Symposium 143. Wiley, Chichester (1989):138–149.
   Google Scholar
• KNUDSON W, BISWAS C, LI X-Q, NEMEC RE, TOOLE BP:The role and regulation of tumor-associated hyaluro-nan. In: The Biology of Hyaluronan. Ciba Foundation Sym-posium 143. Wiley, Chichester (1989):150–169.
   Google Scholar
• ROONEY P, KUMAR S: Inverse relationship between hyaluronan and collagens in development and angio-genesis. Differvntiation (1993) 54:1–9.
   PubMed Web of Science ®Google Scholar
• HAYNES BF, LIAO H-X, PATTON KL: The transmembrane hyaluronate receptor (CD44): multiple functions, mul-tiple forms. Cancer Cells (1991) 3:347–350.
   PubMed Web of Science ®Google Scholar
• HARDINGHAM TE, FOSANG AJ: Proteoglycans: many forms and many functions. EASES J. (1992) 6:861–870.
   Google Scholar
• Proteoglycans have important physical effects on events in the concentrated milieu around the cells and in the extracellular matrix.
   Google Scholar
• UNDERHILL C: CD44: The hyaluronan receptor. J. Cell Sci. (1992) 103:293–298.
   PubMed Web of Science ®Google Scholar
• A useful summary with particular emphasis upon CD44's interaction with hyaluronan and the functional consequences of this interaction.
   Google Scholar
• KNUDSON CB, KNUDSON W: Hyaluronan-binding pro- teins in development, tissue homeostasis, and disease.EASES J. (1993) 7:1233–1241.
   Google Scholar
• This review focuses upon specific hyaluronan-hyaladherin (recep-tor) interactions that affect cell migration, such as cell-cell adhesion and cell differentiation.
   Google Scholar
• ISACKE CM: The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. (1994) 107:2353–2359.
   PubMed Web of Science ®Google Scholar
• This commentary concentrates on the regulation of CD44 by its cytoplasmic domain.
   Google Scholar
• LYNCH SE, COLVIN RB, ANTONIADES HN: Growth factorIn wound healing; single and synergistic effects on partial thickness porcine skin wounds. J. Clin. Invest. (1989) 84:640–646.
   PubMed Web of Science ®Google Scholar
• ARNOLD F, WEST DC: Angiogenesis in wound healing.Pharmacol. Ther. (1991) 52:407–422.
   PubMed Web of Science ®Google Scholar
• CLARK RAF: Biology of dermal wound repair. Dermatol.Clin. (1993) 11:647–666.
   PubMed Web of Science ®Google Scholar
• This review follows the chronology of dermal wound repair.
   Google Scholar
• BENNETT NT, SCHULTZ GS: Growth factors and wound healing: Part II. Role if normal and chronic wound healing. Am. J. Surg. (1993) 166:74–81.
   Google Scholar
• RAGHOW R: The role of extracellular matrix in postinflammatory wound healing and fibrosis. EASES J. (1994)8:823–831.
   Google Scholar
• A discussion of the currently known mechanisms by which the extracellular matrix modulates different facets of the process of tissue remodelling after surgery.
   Google Scholar
• TERVO T, VAN SET IhN GB, PAALLYSAHO T, TARKKANENA, TERVO K: Wound healing of the ocular surface. Ann. Med. (1992) 24:19–27.
   PubMed Web of Science ®Google Scholar
• NISHIDA T: Extracellular matrix and growth factors in corneal wound healing. Curr. Opin. Ophtbalmol. (1993)4:4–13.
   Web of Science ®Google Scholar
• This review summarises recent developments in corneal epithelial wound healing and the possible clinical implications for the treat-ment of various epithelial disorders.
   Google Scholar
• DUA HS, GOMES JAP, SINGH A: Corneal epithelial wound healing. Br. J. Ophthahnol. (1994) 78:401–408.
   PubMed Web of Science ®Google Scholar
• BALAZS EA, BAND P: Hyaluronic acid: its structure and use. Polymers in Cosmetics (1984) 99:65–72.
   Google Scholar
• SCOTT JE: Secondary structure in hyaluronan solutions: chemical and biological implications. In: The Biology of Hyaluronan. Ciba Foundation Symposium 143. Wiley, Chich-ester (1989):6–20.
   Google Scholar
• COMPER WD, LAURENT TC: Physiological function of connective tissue polysaccharides. Pbysiol Rev. (1978) 58:255–315.
   PubMed Web of Science ®Google Scholar
• BALAZS EA, GIBBS DA: The rheological properties and biological function of hyaluronic acid. In: Chemistry and molecular biology of the intercellular matrix. Balazs EA (Ed.). Academic Press, New York (1970):1241–1254.
   Google Scholar
• MATSUMURA G: Rheological studies on proteoglycan. In: Solution properties of polysaccharides. Brant DA (Ed.). American Chemical Society (1981):213–227.
   Google Scholar
• KNOX P, WELLS P: Cell adhesion and proteoglycans.Cell Sci. (1979) 40:77–88.
   PubMedGoogle Scholar
• WEIGEL PH, FULLER GM, LEBOEUF RD: A model for therole of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J. Theor. Biol. (1986) 119:219–234.
   PubMed Web of Science ®Google Scholar
• ZETTER BR, BRIGHTMAN: Cell motility and the extracellulu. matrix. curr. opin. Cell Biol. (1990) ):850–856.
   Google Scholar
• This review discusses the particular matrix domains that influence cell motility, the cellular receptors that respond to these molecules and signal transduction mechanisms that mediate the motile re-sponse.
   Google Scholar
• LESTER BR, MCCARTHY .113: Tumor cell adhesion to theextracellular matrix and signal transduction mecha-nisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev. (1992) 11:31–44.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E: Control of cell motility and tumor Inva-sion by extracellular matrix interactions. Br. J. Cancer (1992) 66:239–242.
   PubMed Web of Science ®Google Scholar
• A demonstration of integrin-associated signalling.
   Google Scholar
• Curry M, MIYAKE K, KINCADE PW, SILORSKI E, BUTCHER EC, UNDERHILL C: The hyaluronate receptor is a mem-ber of the C1)44 (H-CAM) family of cell surface glyco-proteins. J. Cell Biol. (1990) 111:2765–2774.
   PubMed Web of Science ®Google Scholar
• ARUFFO A,STAMENKOVIC I, MELNICK M, UNDERHILL CG, SEED B: CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 61:1303–1313.
   PubMed Web of Science ®Google Scholar
• JALKANEN S, JALKANEN M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fi-bronectin. j. Cell Biol. (1992) 116:817–825.
   PubMed Web of Science ®Google Scholar
• COULDWELL WE, DE TRIBOLET N, ANTEL JP, GAUTHIER T, KUPPNER MC: Adhesion molecules and malignant gllomas: implications for tuunorigenesis. J. Neurosurg. (1992) 76:782–791.
   PubMed Web of Science ®Google Scholar
• FAASSEN AE, SCHRAGER JA, KLEIN DJ, OEGEMA TR, COUCHMAN UR, MCCARTHY JB: A cell surface chondroi-tin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated mela-noma cell motility and invasion. J. Cell Biol. (1992) 116:521–531.
   PubMed Web of Science ®Google Scholar
• JACKSON DG, BUCKLEY J, BELL JI: Multiple variants ofthe human lymphocyte homing receptor CD44 gener-ated by insertions at a signal site in the extracellular domain. J. Biol. Chem. (1992) 268:4732–4739.
   Google Scholar
• SCREATON GR, BELL MV, JACKSON DG, CORNELIS F, GERTHUU, BELL JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA (1992) 89:12160–12164.
   PubMed Web of Science ®Google Scholar
• SCREATON GR, BELL MV, BELL 5, JACKSON DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem. (1993) 268:12235–12238.
   PubMed Web of Science ®Google Scholar
• KNUDSON W, BARTNIK E, KNUDSON CB: Assembly of pericellular matrices by COS-7 cells transfected withCD44 lymphocyte-homing receptor genes. Proc. Natl. Acad. Sci. USA (1993) 90:4003–4007.
   PubMed Web of Science ®Google Scholar
• CD44 receptors do act as matrix-organising/matrix-anchoring func-tional hyaluronan receptors.
   Google Scholar
• FOX SB, FAWCETT J, JACKSON DG, COLLINS I, GAITER KC, HARRIS AL, GEARING A, SIMMONS DL: Normal human tissues in addition to some tumours, express multiple different CD44 isoforms. CancerRes. (1994) 54:4539–4546.
   Web of Science ®Google Scholar
• MIYAKE K, UNDERHILL CB, LESLEY J, KINCADE PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. (1990) 172:69–75.
   PubMed Web of Science ®Google Scholar
• KOSHIISHI I, SHIZARI M, UNDERHILL CB: CD44 can me-diate the adhesion of platelets to hyaluronan. Blood (1994) 84:390–396.
   PubMed Web of Science ®Google Scholar
• BARTOLAZZI A, PEACH R, ARUFFO A, STAMENKOVIC I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. (1994) 180:53–66.
   PubMed Web of Science ®Google Scholar
• ALHO AM, UNDERHILL CB: The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J. Cell Biol. 108:1557-1565.
   Google Scholar
• ASARI A, MIYAUCHI S, TAKAHASHI T, KOHNO K, UCHI-YAMA Y: LocAli7ation of hyaluronic acid, chondroitin sulfate, and CD44 in rabbit cornea. Arch. Histol. Cytol. (1992) 55:503–511.
   PubMed Web of Science ®Google Scholar
• TERPE H-J, STARK H, PREHM P, GUNTHERT U: CD44 variant isoforms are preferentially expressed in basalepithelia of non-malignant human fetal and adult tis-sues. Histochemistiy (1994) 101:79–89.
   PubMedGoogle Scholar
• CD44 variant isoforms are localised in basal layers of epithelium, and hyaluronan synthase occurs in parallel with the presence of CD44s.
   Google Scholar
• LACY BE, UNDERHILL CB: The hyaluronate receptor isassociated with actin filaments. J. Cell Biol. (1987) 105:1395–1404.
   PubMed Web of Science ®Google Scholar
• SATO N, FUNAYAMA N, NAGAFUCHI A, YONEMURA S, TSUKITA SA, TSUKITA SH: A gene family consisting of ezrin, radixin, and moesin. Its specific localization at actin filament/plasma membrance association sites. Curr. Opin. Cell. Biol. (1992) 4: 834–839.
   Google Scholar
• TSUKITA SH, TSUKITA SA, NAGAFUCH1 A, YONEMURA S:Molecular linkages between cadherins and actin filaments in cell-to-cell adherens junction. Corr. Opin. Cell. Biol. (1992) 4: 834–839.
   PubMedGoogle Scholar
• TSUKITA S,OICHI K, SATO N, SAGARA J, KAWAI A, TSUKITA S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. (1994) 126:391–401.
   PubMed Web of Science ®Google Scholar
• ERM family members work as molecular linkers between the cyto-plasmic domain of CD44 and actin-based cytoskeletons.
   Google Scholar
• PEACH RJ, HOLLENBAUGH D, STAMENDOVIC I, ARUFFOA: Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. (1993) 122:275–264.
   Google Scholar
• BENNETT V: Ankyrins. J. Biol. Chem. (1992) 267:8703–8706.
   Google Scholar
• LUNA EJ, HITT AL: Cytoskeleton-plasma membrane in-teractions. Science (1992) 258:955–964.
   PubMed Web of Science ®Google Scholar
• LOKESHWAR VB, FREGIEN N, BOURGUIGNON LYW: Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid mediated adhesion function. J. Cell Biol. (1994) 126:1099–1109.
   PubMed Web of Science ®Google Scholar
• Ankyrin binding to the cytoplasmic domain of CD44 plays a pivotal role in regulating hyaluronan-mediated functions.
   Google Scholar
• KALOMIRIS EL, BOURGUIGNON LYW: Lymphoma pro-tein kinase C is associated with the transmembrane glycoprotein, GP85 and may function in GP85-ankyrin binding. J. Biol. Chem. (1989) 264:8113–8119.
   PubMed Web of Science ®Google Scholar
• BURGUIGNON LYW, KALOMIRIS EL, LODESHWAR VB: Acylation of the lymphoma transmembrane glycopro-tein, GP85 may be required for GP85-ankyrin interac-tion. J.Bio/. Chem. (1991) 266:11761–11765.
   PubMed Web of Science ®Google Scholar
• LOKESWHAR VB, BOURGUIGNON LYW: The lymphoma transmembrane glycoprotein CD44 (G1'85) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J. Biol. Chem. (1992) 267:22073–22078.
   PubMed Web of Science ®Google Scholar
• BOURGUIGNON LYW, LOKESWHAR VB, CHEN X, MERRICK GL: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskele-ton interaction. J. Immunol. (1993) 151:6634–6644.
   PubMed Web of Science ®Google Scholar
• TURLEY EA: Hyaluronan-binding proteins and recep-tors. Advan. Drug Delivery Rev. (1991) 7:257–264.
   Web of Science ®Google Scholar
• TURLEY EA, AUSTEN L, VANDELIGT K, CLARY C: Hyaluro-nan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. (1991) 112:1041–1047.
   PubMed Web of Science ®Google Scholar
• HARDWICK C, HOARE K, OWENS R, HOHN HP, HOOK M, MOORE D, CRIPPS V AUSTEN L, NANCE DM, TURLEY EA: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol. (1992) 117:1343–1350.
   PubMed Web of Science ®Google Scholar
• RHAMM is a new type of hyaluronan receptor that is involved in cell locomotion.
   Google Scholar
• YANG B, ZHANG L, TURLEY EA: Identification of two hyaluronan-binding domains in the hyaluronan recep-tor RHAMM. J. Biol. Chem. (1993) 268:8617-8623. Identification of two domains within RHAMM that are responsible for its hyaluronan binding activity.
   Google Scholar
• TURLEY EA: Hyaluronan and cell locomotion. Cancer Metastasis Rev. (1992) 11:21–30.
   PubMed Web of Science ®Google Scholar
• Hyaluronan-RHAMM interactions regulate directional locomotion of tumour cells and result in enhanced protein tyrosine phosphoryla-tion that may be a critical messenger mechanism for initiation of locomotion.
   Google Scholar
• HALL CL, WANG C, LANGE LA, TURLEY EA: Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine Icinase activ-ity. J. Cell Biol. (1994) 126:575–588
   PubMed Web of Science ®Google Scholar
• Hyaluronan stimulates locomotion via a rapid and transient protein tyrosine kinase signalling event mediated by RHAMM.
   Google Scholar
• FORSBERG N, GUSTAFSON S: Characterization and puri-fication of hyaluronan receptor on liver endothelial cells. Biochim. Biophys. Acta (1991) 1078:12–18.
   PubMed Web of Science ®Google Scholar
• GUSTAFSON S, FORSBERG N, MCCOURT P, WICKSTROM T, BJORKMAN T, LILJA K: Characterization and localiza-tion of the hyaluronan receptor originally found on liver endothelial cells. In: First International Workshop on hyaluronan in Drug Delivery. Willoughby DA (Ed.). Royal Society of Medicine Press (1994):43–59.
   Google Scholar
• MCCOURT PAG, EK B, FORSBERG N, GUSTAFSON S: Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. (1994) 269:30081-30084. Amino acid sequence analysis demonstrates that intercellular adhe-sion molecule-1 is identical with a cell surface receptor for hyaluro-nan.
   Google Scholar
• HYNES RO, YAMADA KM: Fibronectin: Multifunctional modular glycoproteins. J. Cell Biol. (1982) 95:369–377.
   PubMed Web of Science ®Google Scholar
• HYNES R: Molecular biology of fibronectin. Ann. Rev. Cell Biol. (1985) 1:67–90.
   PubMedGoogle Scholar
• RUOSLAHTI E: Intregrins. J. Clin. Invest. (1991) 87:1–5.
   Google Scholar
• HYNES RO: Integrins: versatility, modulation, and sig-naling in cell adhesion. Cell (1992) 69:11–25.
   PubMed Web of Science ®Google Scholar
• FUJIKAWA LS, FOSTER CS, HARRIST TJ, LANIGAN JNI, COLVIN RB: Fibronectin in healing rabbit corneal wounds. Lab. Invest. (1981) 45:120–129.
   PubMed Web of Science ®Google Scholar
• SUDA T, NICHIDA T, OHASHI Y, NAKAGAWA S, MANABE R: Fibronectin appears at the site of corneal stromal wound in rabbits. Curr. Eye Res. (1981/1982) 1:553–556.
   Web of Science ®Google Scholar
• GIPSON IK, WATANABE H, ZIESKE JD: Corneal wound healing and fibronectin. Int. Ophthalmol. Clin. (1993) 33:149–163.
   PubMedGoogle Scholar
• GRUSHKIN -LERNER LS, TRINKAUS -RANDALL V: Localiza-tion of integrin and syndecan in vivo in a corneal epithelial abrasion and keratectomy. Curr. EyeRes. (1991) 10:75–85.
   Web of Science ®Google Scholar
• MURAKAMI J, NICHIDA T, OTORI T: Coordinated appear-ance of beta 1 integrins and fibronectin during corneal wound healing. J. Lab. Clin. Med. (1992) 120:86–93.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, NAKAGAWA 5, AWATA T, OHASHI Y, WATAN-ABE K, MANABE R: Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J. Cell Biol. (1983) 97:1653–1657.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, NAKMURA M, MISHIMA H, OTORI T: Differen-tial modes of action of fibronectin and epidermal growth factor on rabbit corneal epithelial migration. J. Cell. Physiol. (1990) 145:549–554.
   PubMed Web of Science ®Google Scholar
• MIYAUCHI S, SUGIYAMA T, MACHIDA A, SEKTFUCHI T, MIYAZAKI K, TOKUYASU K, NAKAZAWA K: The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. I. An in vitro study. J. OcularPhamacol. (1990) 6:91–99.
   Google Scholar
• NISHIDA T, NAKAMURA M, MISHIMA H, OTORI T: Hyaluronan stimulates corneal epithelial migration. Exp. Eye Res. (1991)53:753–758.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, NAKAMURA M, MISHIMA H, OTORI T: Inter-leuk.in 6 promotes epithil i2lmigration by a fibronectin. dependent mechanism. J. Cell. Physiol. (1992) 153:1–5.
   Google Scholar
• NISHIDA T, NAKAMURAM, MURAKAMI J, MICHIMA H, OTORI T: Epidermal growth factor stimulates corneal epithelial cell attachment to fibronectin through a fibronectin receptor system. Invest, Ophthalmol. Vis. Sci. (1992) 33:2464–2469.
   PubMed Web of Science ®Google Scholar
• NAKAMURA M, NISHIDA T: Role of integrin and fi-bronectin in corneal epithelial migration. Jpn. J. Ophthalmol. (1994) 38:246–251.
   Web of Science ®Google Scholar
• GIPSON IK, WESTCOIT MJ, BROOKSBY NG: Effects of cytochalasin B and D and colchicine on migration of the corneal epithelium. Invest. Ophthalmol. Vis. Sci. (1982) 22:633–642.
   PubMed Web of Science ®Google Scholar
• NAKAMURA M, MISHIMA H, NISHIDA T, OTORI T: Require-ment of microtubuk assembly for initiation of EGF-stimulated corneal epithelial migration. Jpn. J. Ophthalmol. (1991) 35: 377–385.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, NAKAMURA M MISHIMA HJ, HJIKIDA M, OTORI T: Role of intracellular signal transduction system in corneal epithelial migration. Invest. Ophthalmol. Vis. Sci. (1993) 34(Suppl.):1406.
   Google Scholar
• FRIEND J: Physiology of the Cornea: Metabolism and Biochemistry. In: The Cornea: Scientific Foundations and Clinical Practice (2nd ed.)(1987) Smolin G, Thoft RA (Eds.). Little, Brown and Company, Boston (1987):16–38.
   Google Scholar
• FITZSIMMONS TD, MOLANDER N, STENEVI Ti, EAGER-HOLM P, SCHENGOLM M, VON MALMBORG A: Endo-genous hyaluronan in corneal disease. Invest. Ophthalmol. Vis. Sci.(1994) 35:2774–2782.
   PubMedGoogle Scholar
• KITANO S, GOLDMAN JN: Cytologic and histochemical changes in corneal wound repair. Arch. Ophthalmol. (1966) 76:345–354.
   PubMed Web of Science ®Google Scholar
• FITZSIMMONS TD, FAGERHOLM P, HARFSTRAND A, SCHENHOLMT M: liyaluronic acid in the rabbit cornea after excimer laser superficial keratectomy. Invest. Ophthalmol. Vis. Sci. (1992) 33:3011–3016.
   PubMed Web of Science ®Google Scholar
• FAGERHOLM P, FITZSIMMONS T, HARFSTRAND A, SHEN-HOLM M: Reactive formation of hyaluronk acid in the rabbit corneal alkali burn. Ada Ophthalmol. (1992) 70:67–72.
   Google Scholar
• FAGERHOLM P, FITZSIMMONS T, HARFSTRAND A, SCHEN-HOLM M: Reactive formation of hyaluronic add after small and large lens injury. Acta Ophthalmol. (1992) 70\(Suppl. 205):58–64.
   Google Scholar
• FITZSIMMONS TD, FAGERHOLM P, HARFSTRAND A, SCHENHOLM M: Hyaluronic acid in the rabbit conea after excimer laser superficial keratectomy. Invest. Ophthalmol. Vis, Sci. (1992) 33:3011–3016.
   PubMed Web of Science ®Google Scholar
• FAGERHOLM P, FITZSIMMONS T, HARFSTRAND A, SCHEN-HOLM M: Reactive formation of hyaluronic acid in the rabbit corneal alkali burn. Acta Ophthalmol. (1992) 70\(Suppl. 202):67–72.
   Google Scholar
• MOLANDER N, SINDQUIST U, STENEVI U, VON MAIM-BORG A, EHINGER B: Influence of radial keratotomy on endogenous hyaluronan in cornea and aqueous humor. Refract. Corneal Surg. (1993) 9:358–365.
   PubMedGoogle Scholar
• MOLANDER N, EHINGER B, ROLFSON W, HARFSTRAND A, STENEVI U: Histochemical identification of hyaluronan in the rabbit anterior segment during the healing pe- nod after extracapsular lens extraction. Acta Ophthal-mol. (1993) 71:336–346.
   PubMed Web of Science ®Google Scholar
• FAGERHOLM P, HAMBERG-NYSTROM H, TENGROTH B: Wound healing and myopic regression following pho-torefractive keratomy. Acta Ophthalmol. (1994) 72:229–234.
   Web of Science ®Google Scholar
• WGGLI P, GRABERW: Ultrastructural distribution of hyaluronan in rat cornea. Exp. Eye Res. (1993) 56:693–699.
   PubMed Web of Science ®Google Scholar
• RITTIG M, LUTJEN-DRECOLL E, PREHM P: Iffununohisto-chemical localization of hyaluronan synthase in cornea and conjunctiva of cynomolgus monkey. Exp. Eye Res, (1992) 54:455–460.
   PubMed Web of Science ®Google Scholar
• NAKAMURA M, KIKLDA M, NAKANO T: Concentration and molecular weight dependency of rabbit corneal epi-thelial wound healing on hyaluronan. Curr. Eye Res. (1992) 11:981–986.
   PubMed Web of Science ®Google Scholar
• Hyaluronan stimulates epithelial migration in vitro and in vivo. The migration depends on the concentration of hyaluronan, but not its molecular weight.
   Google Scholar
• SUGIYAMA T, MIYAUCHI S, MACHIDA A, MIYAZAKI K, TOKUYASU K, NAKAZAWAK: The effect of sodium hyaluronate on the migration of rabbit corneal epithe-lium. IL The effect of topical administration. J. Ocular Pharmacol. (1991) 7:53–64.
   PubMedGoogle Scholar
• NAKAMURA M, MISHIMA H, NISHIDA T, OTORI T: Binding of hyaluronan to plasma fibronectin increases theattachment of corneal epithelial cells to a fibronectin matrix. J. Cell. Physiol. (1994) 159:415–422.
   PubMed Web of Science ®Google Scholar
• Hyaluronan binds to a fibrin-, and heparin-binding domain at the N-terminal of plasma fibronectin and facilitates the attachment of epithelial cells.
   Google Scholar
• HAKANSSON L, VENGE P: The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J. Immunol. (1985) 135:2735–2739.
   PubMed Web of Science ®Google Scholar
• YAMADA KM, KENNEDY DW, KIMATA K, PRATT RM: Characterization of fibronectin interactions with gly-cosaminoglycans and identification of active pro-teolytic fragments. J. Biol. Chem. (1980) 255:6055–6063.
   PubMed Web of Science ®Google Scholar
• LATERRA J, GULP LA: Differences in hyaluronate binding to plasma and cell surface fibronectins. J. Biol. Chem. (1982) 257:719–726.
   PubMed Web of Science ®Google Scholar
• ISEMURA M, YOSHIZAWA Z, KOIDE T, ONO T: Interaction of fibronectin and its proteolytic fragments with hyaluronic acid. J. Biochem. (1982) 91:731–734.
   PubMed Web of Science ®Google Scholar
• SEKIGUCHI K, HAKOMORI S, FUNAHASHI M, MATSU-MOTO I, SENO N: Binding of fibronectin and its pro-teolytic fragments to glycosaminoglycans. J. Biol. Chem. (1983) 258:14359–14365.
   PubMedGoogle Scholar
• NAKAMURA M, NISHIDA T, HIKIDA M, OTORI T: Com- bitted effects of hyaluronan and fibronectin on corneal epithelial wound closure of rabbit in vivo. Curr. Eye Res. (1994) 13:385–388.
   PubMed Web of Science ®Google Scholar
• Hyaluronan and fibronectin have a synergistic effect, with fibronectin pretreatment augmenting hyaluronan-stimulated corneal epithelial migration.
   Google Scholar
• BERNATCHEZ SF: Use of hyaluronic acid in ocular ther-apy. In: Biopbarmaceutics of ocular drug delivery. Edman P (Ed.). CRC Press, Boca Raton (1993):106–120.
   Google Scholar
• NAGAHARA M, SHOJI N, SHIMIZU K, MIYAUCHI S: Viscoe-lastic material protection of the corneal endothelium during phacoemulsification. Jpn. J. Ophthalm. Surg. (1993) 6:459–463.
   Google Scholar
• NISHIDA T, NAKAGAWA S, AWATA T, TANI Y, MANABE R: Fibronectin eyedrops for traumatic recurrent corneal erosion. Lancet H (1983):521–522.
   Google Scholar
• NISHIDA T: Role of fibronectin in the corneal epithelial wound healing. In: The Cornea: Transactions of the World Congress on the Cornea HI. Cavanagh HD (Ed.). Raven Press, New York (1988):619–625.
   Google Scholar
• DANIELE S, GILBARD JP, SCHEPENS CL: Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study. Graefe's Arch. Clin. Exp. Ophthalmol. (1992) 230:314–317.
   PubMed Web of Science ®Google Scholar
• CELLINI M, BALDI A, CARAMAZZA N, DE FELICE GP, GAZZANIGA A: Epidermal growth factor in the topical treatment of herpetic corneal ulcers. Ophthalmologica (1994) 208:37–40.
   PubMed Web of Science ®Google Scholar
• KITANO S, OTORI T, MASUDA K, KOMEMUSHI S: Clinical effect of sodium hyaluronate ophthalmic solution on keratoconjunctival epithelial disorders. Folia ophthal-mot jpn. (1993) 44:487–497.
   Google Scholar
• KITANO S, OTORI T, MASUDA K: Effect of 0.3% sodium hyaluronate ophthalmic solution on severe keratocon-junctival epithelial disorders. J. Eye (1993) 10:603–610.
   Google Scholar
• ITOI M, KIM O, KIMURA T, KANAI A, MOMOSE T, KANKI K, YAMAGUCHI T, UENO S, KUROKAWA M, KOMEMUSHI S: The effect of sodium hyaluronate ophthalmic solu-tion on corneal epithelial disorders in contact lens wearers. J. Eye (1993) 10:617–626.
   Google Scholar
• HAMANO T, HORIMOTO Y, LEE M, KOMEMUSHI S: Evalu-ation of the effect of sodium hyaluronate ophthalmic solution on corneal dessiccation due to hard contact lens wear. J. Eye (1993) 10:627–630.
   Google Scholar
• NAKAMURA M, HIKIDA M, NAKANO T, ITO S, HAMANO T, KINOSHITA S: Characterization of water retentive prop-erties of hyaluronan. Cornea (1993) 12:433–436.
   PubMed Web of Science ®Google Scholar
• HOLLY FJ, LEMP MA: Tear physiology and dry eyes. Sum Ophthalmol. (1977) 22:69–87.
   PubMed Web of Science ®Google Scholar
• BRON AJ: Prospects for dry eye. Trans. Ophthalmol. Soc. UK (1985) 104:801–811.
   PubMedGoogle Scholar
• POLACK FM, MCNIECE MT: The treatment of dry eyes with Na hyaluronate (Heaton). A preliminary report. Cornea (1982) 1:133–136.
   Google Scholar
• STUART JC, LINN JG: Dilute sodium hyaluronate (Heaton) in the treatment of ocular surface disorders. Ann. Ophthalmol. (1985) 17:190–192.
   PubMed Web of Science ®Google Scholar
• MENGHER LS, PANDHER KS, BRON AJ, DAVEY CC: Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. Br. J. Opbthalmol. (1986) 70:442–447.
   Google Scholar
• SHIMMURA S, MAJIMA Y, SHIMAZAKI J, YAMADA M, FUK-AGAWA K, OGAWA Y, NOUKA K, ONO M, OHTAKE Y, SATO N, YOSHINO K, NEGORO K, TAKANO H, YOSHINO K, TAKAMURA E, KOMEMUSHI S, TODA I, FUJISHIMA H, TSUBOTA K: The effect of sodium hyaluronate ophthal-mic solution on dry eye. J. Eye (1993) 10:611–616.
   Google Scholar
• HELLSTROM S, LAURENT C: Hyaluronan and healing of tympanic membrane perforations. Acta Otolaryn-gologica (1987) 442(Suppl.):54–61.
   Google Scholar
• LAURENT C, HELLSTROM S, FELLENIUS E: Hyaluronan improves the healing of experimental tympanic membrane perforations. Arch. Otolaryngol. Head Neck Stag. (1988) 114:1435–1441.
   PubMed Web of Science ®Google Scholar
• HELLSTROM S, BLOOM GD, BERGHEM L, STENFORS LE, SODERBERG O: A comparison of hyaluronan and fi-bronectin in the healing of tympanic membrane perfo-rations. Eur. Arch. Otorhinolaryngol. (1991) 248:230–235.
   PubMed Web of Science ®Google Scholar
• SPANDOW O, HEIISTROM S: Animal model for persist- ent tympanic membrane perforations. Ann. Otol. Rhinot Laryngol. (1993) 102:467–472.
   PubMed Web of Science ®Google Scholar
• Hyaluronan stimulates the healing rate of the hydrocortisone-in-duced chronic tympanic membrane perforation.
   Google Scholar
• STENFORS LE: Treatment of tympanic membrane perfo-rations with hyaluronan in an open pilot study of unselected patients. Acta Otolaryngologica (1987) 442(Suppl.):81–87.
   Google Scholar
• STENFORS LE: Repair of traumatically ruptured tym-panic membrane using hyaluronan. Acta Otolaryn-gologica (1987) 442(Suppl.):88–91.
   Google Scholar
• CAMARDA V, CERVELLINI M, PEDACE G, PACE M: Sodium hyaluronate in the repair of perforations of the tym-panic membrane. Clinical Therapeutics (1989) 11:744–754.
   PubMed Web of Science ®Google Scholar
• LAURENT C, SODERBERG O, ANNIKO M, HARTWIG S: Repair of chronic tympanic membrane perforations using applications of hyaluronan or rice paper pros-theses. ORL (1991) 53:37–40.
   Google Scholar
• LACARTE MPR, CASASIN T, ALONSO A: The effects of sodium hyaluronate on tympanic membrane perfora-tions. I Int. Med. Res. (1992) 20:353–359.
   PubMed Web of Science ®Google Scholar
• LACARTE MPR, CASASIN T, PUMAROLA F, ALONSO A: An alternative treatment for the reduction of tympanic membrane perforations: sodium hyaluronate. A dou- ble blind study. Acta Otolaryngol. (1990) 110:110-114. Hyaluronan stimulates healing of tympanic membrane perforations in a double blind study.
   Google Scholar
• CASADEL A, BASSETTO F, AZZENA B, BURN P, DE GALATEO A, ABRATANGELO G: Effect of some chemical substances on wound healing. In: Cutaneous Develop-ment, Aging and Repair. Abratangelo G, Davidson JM (Eds.). Liviana Press, Padova, Italy (1989):189–196.
   Google Scholar
• FOSCHI D, CASTOLDI L, RADAELLI E, ABELLI P, CALDERINI G, RASTRELLI A, MARISCOTTI C, MARAZZI M, TRABUCCHI E: Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats. Int. J. Tiss. Reac. (1990) 12:333–339.
   PubMedGoogle Scholar
• KING SR, HICKERSON WL, PROCTOR KG: Beneficial ac-tions of exogenous hyaluronic acid on wound healing. Surgery (1991) 109:76–84.
   PubMed Web of Science ®Google Scholar
• BURD DA, GRECO RM, REGAUER 5, LONGAKER MT, SIE- BERT JW, GARG HG: Hyaluronan and wound healing: a new perspective. Brit. J. Plan. Surg. (1991) 44:579-584. Hyaluronan-associated proteins are important in initiating the wound repair.
   Google Scholar
• BABU R, GUPTA S, DATTA K: Elevated level of hyaluronic acid binding protein in diabetic rats. Biochem. Int. (1990) 22:877–886.
   PubMedGoogle Scholar
• ABRATANGELO G, MARTELLI M, VECCHIA P: Healing of hyaluronic acid-enriched wounds: histological obser-vations. J. Surg. Res. (1993) 35:410–416.
   Google Scholar